Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse
Open accessThe DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index; none of the 207 sources its claims cite is checked for support yet.
Abstract
Anhedonia, defined as the state of reduced ability to experience feelings of pleasure, is one of the hallmarks of depression. Hedonic tone is the trait underlying one's characteristic ability to feel pleasure. Low hedonic tone represents a reduced capacity to experience pleasure, thus increasing the likelihood of experiencing anhedonia. Low hedonic tone has been associated with several psychopathologies, including major depressive disorder (MDD), substance use, and attention-deficit hyperactivity disorder (ADHD). The main neural pathway that modulates emotional affect comprises the limbic-cortical-striatal-pallidal-thalamic circuits. The activity of various components of the limbic-cortical-striatal-pallidal-thalamic pathway is correlated with hedonic tone in healthy individuals and is altered in MDD. Dysfunction of these circuits has also been implicated in the relative ineffectiveness of selective serotonin reuptake inhibitors used to treat anxiety and depression in patients with low hedonic tone. Mood disorders such as MDD, ADHD, and substance abuse share low hedonic tone as well as altered activation of brain regions involved in reward processing and monoamine signaling as their features. Given the common features of these disorders, it is not surprising that they have high levels of comorbidities. The purpose of this article is to review the neurobiology of hedonic tone as it pertains to depression, ADHD, and the potential for substance abuse. We propose that, since low hedonic tone is a shared feature of MDD, ADHD, and substance abuse, evaluation of hedonic tone may become a diagnostic feature used to predict subtypes of MDD, such as treatment-resistant depression, as well as comorbidities of these disorders.
Overview
CoChat Summary
TL;DR
This narrative review proposes that low hedonic tone is a shared neurobiological feature of treatment-resistant depression (TRD), attention-deficit hyperactivity disorder (ADHD), and substance abuse, linked to dysfunctional reward circuitry including the ventromedial prefrontal cortex, subgenual anterior cingulate cortex, and nucleus accumbens. It suggests hedonic tone may help predict MDD subtypes such as TRD and comorbidities with ADHD and substance abuse.
Key findings
- Low hedonic tone is associated with MDD, substance use, and ADHD, and the review argues it may serve as a diagnostic feature for predicting TRD and comorbidities of MDD with ADHD and substance abuse.
- The paper reports comorbidity figures: depression occurs in 9%–50% of patients with ADHD; approximately one third of patients with MDD in STAR*D also have a substance use disorder; among respondents with ADHD, odds ratios are 2.7–7.5 for mood disorders, 1.5–5.5 for anxiety disorders, 1.5–7.9 for substance use disorders, and 3.7 for intermittent explosive disorder.
- In patients referred to a tertiary care center, 32.5% of TRD met criteria for ADHD, and the best predictors of comorbid ADHD with TRD were the number of SSRIs and, less specifically, the number of antidepressants failed.
- The review states that anhedonic depressed patients show decreased prefrontal activity and increased activity in the VMPFC and sgACC, and that normalization of activity in these regions is associated with improvement of anhedonia.
Methods
- Narrative review based on a literature search of PubMed, PsychNET, and Medline databases until January 2016 using keywords “hedonic tone” AND “mood disorder” AND any of “reward pathways,” “dopamine,” “neurobiology,” “depression,” “ADHD,” or “substance abuse.”
- Inclusion criteria were English-language articles published in peer-reviewed journals and original research or review articles; human and nonhuman primate studies were included in the neurobiology of mood and hedonic tone section, while all other sections included only human studies.
- The paper synthesizes neuroimaging, pharmacological, and clinical studies rather than conducting a meta-analysis or primary data analysis.
Limitations
- The paper states that assessment of hedonic tone is complicated by the lack of reliable methods; currently used methods include the Snaith-Hamilton Pleasure Scale, the Dimensional Anhedonia Rating Scale, and the Scale for the Assessment of Negative Symptoms, with the Dimensional Anhedonia Rating Scale having the best reliability and validity.
- The paper states that currently available assessments evaluate the current state of hedonic tone and do not take into account its long-term aspects, so novel assessment methods are required to properly assess the lifelong trait of hedonic tone.
- Evident from the text: this is a hypothesis-generating narrative review, not a systematic review or meta-analysis, and it does not report formal risk-of-bias assessment or quantitative synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
0 Valid · 0 Not valid · 129 Not checked · 37 Own results and interpretations
A statement the paper makes itself — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Low hedonic tone has been associated with several psychopathologies, including major depressive disorder (MDD), substance use, and attention-deficit hyperactivity disorder (ADHD).”
§ Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A statement the paper makes itself — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Dysfunction of these circuits has also been implicated in the relative ineffectiveness of selective serotonin reuptake inhibitors used to treat anxiety and depression in patients with low hedonic tone.”
§ Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Low hedonic tone has been associated with several psychopathologies, including major depressive disorder (MDD), substance use, and schizophrenia,8,9 although variations in hedonic tone can also be observed in healthy individuals.10”
§ Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse > Introduction
What the sources say
- Not checked yetcites [8] Snaith RP Identifying depression: the significance of anhedonia Hosp Pract (Off Ed) 1993 28 9A 55 60 8408359
- Not checked yetcites [9] Snaith RP Hamilton M Morley S Humayan A Hargreaves D Trigwell P A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale Br J Psychiatry 1995 167 1 99 103 7551619
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The main neural pathway that modulates emotional affect comprises the limbic–cortical–striatal–pallidal–thalamic circuits.”
- Also stated in: § Neurobiology of mood disorders · plain
“The main neural pathway that modulates emotional affect comprises the limbic–cortical–striatal–pallidal–thalamic (LCSPT) circuits, which consist of connections between the orbital and medial prefrontal cortex (OMPFC), ventromedial striatum, ventral pallidum, hippocampal subiculum, mediodorsal and midline thalamic nuclei, and amygdala.18”
§ Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse > Abstract
What the sources say
- Not checked yetcites [18] Ongur D Ferry AT Price JL Architectonic subdivision of the human orbital and medial prefrontal cortex J Comp Neurol 2003 460 3 425 449 12692859
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Neurobiology of mood disorders · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Recent research into the neurobiology of anhedonia has focused on neurobiology of reward and motivation and has identified associated dopaminergic circuits as playing a key role in the maintenance of hedonic tone,2,4,15,16 specifically neural circuits that contain bottom-up and top-down projections into the prefrontal cortex (PFC), lateral habenula, and the ventral tegmental area (VTA) dopamine (d”
§ Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse > Introduction
What the sources say
- Not checked yetcites [2] Russel J Emotion, core affect, and psychological construction Cogn Emotion 2009 23 7 1259 1283 PMC2835153 20221411
- Not checked yetcites [4] Stein DJ Depression, anhedonia, and psychomotor symptoms: the role of dopaminergic neurocircuitry CNS Spectr 2008 13 7 561 565 18622360
- Not checked yetcites [15] Bevins RA Besheer J Novelty reward as a measure of anhedonia Neurosci Biobehav Rev 2005 29 4–5 707 714 15876456
- Not checked yetcites [16] Knutson B Fong GW Adams CM Varner JL Hommer D Dissociation of reward anticipation and outcome with event-related fMRI Neuroreport 2001 12 17 3683 3687 11726774
- Not checked yetcites [17] Lammel S Tye KM Warden MR Progress in understanding mood disorders: optogenetic dissection of neural circuits Genes Brain Behav 2013 13 1 38 51 23682971
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
104 more claims
Create a free account to see all 166 claims and to verify the 207 references still open.
- It may state two separate claims as one. 51
- Probably not a substantial claim. 10
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Anhedonia is a state of reduced ability to experience feelings of pleasure and is a common symptom of MDD reported in ~75% of patients (Franken et al., 2007;Sternat and Katzman, 2016).”
From Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment (2021) · cites this paper as Sternat and Katzman, 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, the same brain regions and neurotransmitter systems that underlie ADHD are also implicated in the psychiatric disorders that are frequently comorbid with ADHD (19-21).”
From The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple psychiatric comorbidities, including depression and anxiety (16, 17), are thought to be mediated in part by shared neurobiological pathways that are also implicated in the pathophysiology of ADHD (19, 20).”
From The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sternat et al. (2016) who reported that 34% of patients referred for treatment resistant depression (TRD) met criteria for ADHD with predictors of this comorbidity including selective serotonin reuptake inhibitor (SSRI) failure and chronic anhedonia [52].”
From Adult ADHD and comorbid disorders: clinical implications of a dimensional approach (2017) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Emotional blunting and anhedonia have been implicated in disturbances of central dopaminergic, mesolimbic, and mesocortical reward circuit pathways (Pan et al., 2017;Sternat and Katzman, 2016).”
From Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment (2021) · cites this paper as Sternat and Katzman, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse > Neurobiology of mood disorders
“Selective serotonin reuptake inhibitors (SSRIs) fluoxetine and paroxetine have been shown to increase glucose metabolism in the PFC, particularly the dorsolateral, ventrolateral, and medial aspects, parietal cortex, and the sgACC.”
§ Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse > Neurobiology of mood disorders
“In addition, fluoxetine reduced glucose metabolism in the sgACC, hippocampus, insula, and pallidum.”
Citations
Cites
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“145,146 It has been reported that depression occurs in 9%–50% of patients with ADHD, 147 and STAR*D study has reported that approximately a third of patients with MDD also have a substance use disorder.”
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 1×
“Mayberg et al 31 investigated whether chronic DBS could modulate the activity of the sgACC over 6 months among patients with TRD, defined as failure to respond to a minimum of four different anti-depressant treatments during the current major depressive episode lasting at least 1 year.”
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 3×
“7 for intermittent explosive disorder.(145) Sternat et al reported that in patients referred to a tertiary care center, 32.”
InfluentialAre the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
Fanselow, M. S., & Dong, H.-W. (2010) · Neuron · doi:10.1016/j.neuron.2009.11.031 · Cited by 3,358 · cited 2×
“46 Whereas the dorsal part of the hippocampus is primarily involved in memory consolidation, the ventral hippocampus has been shown to modulate emotions and mood.”
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203 · cited 1×
“34 Functional imaging studies have shown that the amygdala is activated by fear conditioning, 35 and patients with lesions to the amygdala are unable to recognize fearful stimuli.”
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“The monoamine hypothesis of depression postulates that depression is caused by decreased modulating function of serotonin, NE, or DA in the brain.(62) Nevertheless, this theory does not explain the apparent lack of efficacy in a relatively large subset of patients with treatment-resistant”
The amygdala: vigilance and emotion
Davis, M., & Whalen, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000812 · Cited by 2,882 · cited 2×
“38 In addition, the amygdala also has reciprocal connections with cortical regions involved in the processing and evaluation of sensory information.”
Ongur, D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.206 · Cited by 2,627
Research works printed but not linked: 1
- [26]Ongur D An X Price JL Prefrontal cortical projections to the hypothalamus in macaque monkeys J Comp Neurol 1998 401 4 480 505 9826274
Cited by
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732
“This deficit in reward processing characterized as low hedonic tone [51, 52], is hypothesized to be at least in part related to deficits in modulation of this circuitry [53].”
BackgroundSelf-citationFaraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
The Urban Built Environment, Walking and Mental Health Outcomes Among Older Adults: A Pilot Study
Roe, J. J., Mondschein, A. S., Neale, C., Barnes, L. E., Boukhechba, M., & López, S. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.575946 · Cited by 166
Sheth, C., McGlade, E., & Yurgelun-Todd, D. (2017) · Chronic Stress · doi:10.1177/2470547017715645 · Cited by 131
Fagiolini, A., Florea, I., Loft, H., & Christensen, M. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.106 · Cited by 127
Metadata
- Authors
- Katzman, M., & Sternat, T.
- Affiliations
- START Clinic (CA)
- Corresponding author
- Katzman, Martin
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2016-08
- Volume
- Volume 12
- Pages
- 2149-2164
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC5003599
- OpenAlex
- W2509397462
- Cited by
- 83
- References
- 173
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 9 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 8 · 2019: 8 · 2018: 10 · 2017: 9
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- hedonic tone, anhedonia, treatment-resistant depression, attention deficit hyperactivity disorder, substance abuse, major depressive disorder, reward processing, monoamine signaling, selective serotonin reuptake inhibitors, comorbidities, depression subtypes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. https://app.cochat.ai/papers/10.2147/ndt.s111818
- The paper
- Katzman, M., & Sternat, T. (2016). Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s111818
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.